Role of Epigenetics in Cancer

Presentation by Shukuru Rushanika about the role of epigenetics in skin cancer. In particular, how does the FDA-approved drug “DAC” interact with squamous carcinoma cells that bear mutations in gene pathways making them grow uncontrollably? Shukuru Rushanika has a B.S. from the University of Northern Colorado. Currently he is working at the Anschutz Medical Campus, in the Dennis Roop laboratory. Shukuru’s accomplishments range from Princeton MOL BIO scholar, Harvard BSCP student, Ford Fellowship Honorable Mention, and McNair Scholar.